What are the characteristics of PHILIPS KON stock?

PHILIPS KON is a company operating in the Dispositifs médicaux sector. The stock is listed on Euronext Amsterdam under ISIN NL0000009538.

What is the recent price evolution of PHILIPS KON stock?

Since last close: -0.16 %. Over one week: 1.42 %. Over one year: 1.25 %.

Philips Secures FDA Approval for AI-Enhanced Spectral CT Scanner

Royal Philips announced on Thursday that it has received FDA 510(k) clearance for its Philips Spectral CT Verida system, a medical imaging innovation that combines persistent spectral imaging with AI-driven reconstruction. This system is touted as the first spectral CT detector utilizing AI.

Published on Apr 22, 2026 at 15:05

Philips Secures FDA Approval for AI-Enhanced Spectral CT Scanner

PHILIPS KON

24.24 € -0.16 %

Add us as a preferred source on Google

Enhanced Imaging Capabilities

The Verida system integrates persistent spectral imaging with AI reconstruction to enhance image quality, efficiency, and diagnostic capabilities. This technology is targeted at the fields of radiology, cardiology, and oncology.

Free · Every morning

Technical market signals, before the opening bell.

Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.

✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis

Indicative data. No investment advice. Unsubscribe at any time.

🏢 Other stocks — Santé

🗞️ Sanofi raises its 2026 targets after a third quarter with a 14.3% increase, driven by Dupixent 🗞️ OSE Immunotherapeutics: Combi-TED meets its objective, not the Bayesian threshold 🗞️ Emeis: revenue up 6% organically over nine months, occupancy at 90.2% 🗞️ Equasens: €181.8M in revenue over nine months, organic growth at 0.9%

Context

Period

Period: S1 2026

Key reported figures

Revenue: 8 265 millions d'euros
Quarterly revenue: 8 265 millions d'euros
Net income: 535 millions d'euros
5 676 millions d'euros

Outlook / guidance

Expected revenue: 18 503 millions d'euros
Management commentary: « Comparable sales growth: 3%-4.5% »

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Enhanced Imaging Capabilities

Context

Also read